MedTrace Logo

Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras

NCT01651013 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-03-24

No results posted yet for this study

Summary

The purpose of this study is to describe the treatments received and outcomes of patients with metastatic colorectal cancer, what percentage of these patients have K-Ras mutation of the tumor, and to describe the costs of treatments. Information will also be collected regarding risk factors, variables among treatment centers and patients, and explorative analyses will be done to try to identify factors that impact prognosis and factors that predict tolerability and response to treatment.

Conditions

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • R. V. Iaffaioli, M.D. · National Cancer Institute, Naples

  • G. Nasti, M.D. · National Cancer Institute, Naples

  • M. C. Piccirillo, M.D. · National Cancer Institute, Naples

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01651013 on ClinicalTrials.gov